Tokyo, Sept 10, 2004 (JCN) - Mitsubishi Corp. (MC; TSE: 8058) announced September 8 that its wholly owned venture subsidiary Vitamin C60 Bioresearch has discovered a unique property of water-soluble fullerene, a kind of nanotechnology material, in collaboration with Hiroshima Prefectural University Professor Nobuhiko Miwa$BCT(B research group.
The joint research team revealed that the administration of a small amount of water-soluble fullerene effectively suppresses the generation of melanin in melanin-producing cells in the skin. This discovery may pave the way for developing innovative whitening skin care products.
Currently, Vitamin C60 Bioresearch is marketing fullurene-based products like BioFullerene (refined fullurene) and Radical Sponge (water-soluble fullurene) for applications in the life science business.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
Company Profile | Print | Alerts
 |
|
Mitsubishi Corporation and Chiyoda Reach Agreement for Construction of New Ulaanbaatar International Airport in Mongolia
(May 14, 2013)
|
|
Mitsubishi Corporation New Strategic Direction: "Charting a New Path toward Sustainable Growth"
(May 8, 2013)
|
|
Mitsubishi Heavy Industries, Hitachi and Mitsubishi Corporation Launch Smart Community System Demonstration Project in Malaga, Spain
(Apr 26, 2013)
|
|
Mitsubishi Gas Chemical and Mitsubishi Corporation Sign Project Development Agreement for Establishment of Methanol & Dimethyl Ether Production in Trinidad and Tobago
(Apr 9, 2013)
|
|
JAPEX and Mitsubishi Corporation Announce Oil Production in Indonesia's Terang Gas Field Reaches 10 Million Barrels
(Mar 19, 2013)
|
|
The First Solar Investment in Italy for Mitsubishi Corporation and INCJ
(Mar 19, 2013)
|
|
Mitsubishi Corporation acquires Kirin Holdings' Food Science Business
(Mar 18, 2013)
|
|
Kirin and Mitsubishi Corporation Agree on Partial Transfer of Yokohama Akarenga Shares
(Mar 14, 2013)
|
|
MMC, MC, YSH and FMI sign a Memorandum of Understanding on the after-sales service business for Mitsubishi Motors in Myanmar
(Feb 15, 2013)
|
|
Fast Retailing and Mitsubishi Corporation Conclude Agreement to Establish a Joint Venture and the First UNIQLO Store in Indonesia
(Feb 13, 2013)
|
|
|
|
 |
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|
|
 |
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|
|
 |
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|
|
 |
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|